Vaccine manufacturing capacity a major constraint for COVAX
GAVI – The Vaccine Alliance says that manufacturing capacity is one of the major constraints facing
Government pushes for production of cheaper medicines
Government is overhauling its policy on intellectual property to ensure the production of cheaper